Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Código de la empresaHBIO
Nombre de la empresaHarvard Bioscience Inc
Fecha de salida a bolsaOct 21, 2013
Fundada en2000
Director ejecutivoMr. James W. (Jim) Green
Número de empleados330
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 21
Dirección84 October Hill Rd
CiudadHOLLISTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01746-1371
Teléfono15088938999
Sitio Webhttps://www.harvardbioscience.com/
Código de la empresaHBIO
Fecha de salida a bolsaOct 21, 2013
Fundada en2000
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos